Bedum, Netherlands

Durk Dijkstra

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Durk Dijkstra. Retrieved from https://idiyas.com/inventor/durk-dijkstra-c3joxwtx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Durk Dijkstra: Innovator in Medicinal Chemistry

Introduction

Durk Dijkstra is a notable inventor based in Bedum, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that affect the dopaminergic system.

Latest Patents

Durk Dijkstra holds a patent for "2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use." This invention relates to specific chemical compounds that have potential applications in the preparation of medicaments. The compounds are characterized by a general formula that includes various substituents, which can be tailored for specific therapeutic effects.

Career Highlights

Throughout his career, Durk Dijkstra has focused on innovations that enhance the understanding and treatment of conditions related to the central nervous system and circulation. His work has led to advancements in pharmaceutical compositions that leverage the unique properties of his patented compounds.

Collaborations

Durk has collaborated with notable professionals in his field, including Håkan Vilhelm Wikström and Per Erik Andrén. These collaborations have contributed to the development and refinement of his innovative ideas.

Conclusion

Durk Dijkstra's contributions to medicinal chemistry exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and collaborative efforts highlight the importance of research and development in creating effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…